共 50 条
- [42] Risk scoring system for predicting axillary response after neoadjuvant chemotherapy in initially node-positive women with breast cancer [J]. SURGICAL ONCOLOGY-OXFORD, 2018, 27 (02): : 158 - 165
- [44] Reply to the letter on sentinel lymph node biopsy after neoadjuvant chemotherapy in patients with node-positive breast cancer [J]. Breast Cancer Research and Treatment, 2021, 188 : 327 - 328
- [45] Sentinel lymph node biopsy after neoadjuvant chemotherapy predicts pathological axillary lymph node status in breast cancer patients with clinically positive axillary lymph nodes at presentation [J]. International Journal of Clinical Oncology, 2013, 18 : 547 - 553
- [50] Omission of axillary lymph node dissection after neoadjuvant chemotherapy for clinically node-positive breast cancer: How can we select patients? [J]. BREAST JOURNAL, 2020, 26 (09): : 1869 - 1870